After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Bicara Therapeutics Inc is $1.01B. A total of 1.14 million shares were traded on the day, compared to an average of 628.36K shares.
In the most recent transaction, Hyep Ivan sold 17,795 shares of BCAX for 18.55 per share on Nov 24 ’25. After the transaction, the Chief Financial Officer now owns 145,355 company shares. In a previous transaction on Nov 21 ’25, Hyep Ivan sold 605 shares at 18.15 per share. BCAX shares that Chief Financial Officer owns now total 145,355.
Among the insiders who sold shares, Cohlhepp Ryan disposed of 12,500 shares on Nov 21 ’25 at a per-share price of $18.05. This resulted in the President and COO holding 193,641 shares of BCAX after the transaction. In another insider transaction, Mazumdar Claire sold 41,163 shares at $18.86 per share on Nov 24 ’25. Company shares held by the Chief Executive Officer now total 309,892.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BCAX has a high of $22.67 and a low of $7.80.
As of this writing, BCAX has an earnings estimate of -$0.67 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.57 per share and a lower estimate of -$0.73. The company reported an EPS of -$0.39 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCAX is Buy with a score of 4.60.
